We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 22nd:
Ardmore Shipping Corporation (ASC - Free Report) : This company engaged in the seaborne transportation of petroleum products and chemicals has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 32.5% over the last 60 days.
CorMedix, Inc. (CRMD - Free Report) : This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.9% over the last 60 days.
Arcimoto, Inc. : This manufacturer of three-wheeled electric vehicles has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 26.1% over the last 60 days.
Ovid Therapeutics Inc. (OVID - Free Report) : This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25.4% over the last 60 days.
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for April 22nd
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 22nd:
Ardmore Shipping Corporation (ASC - Free Report) : This company engaged in the seaborne transportation of petroleum products and chemicals has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 32.5% over the last 60 days.
Ardmore Shipping Corporation Price and Consensus
Ardmore Shipping Corporation price-consensus-chart | Ardmore Shipping Corporation Quote
Ardmore Shipping’s shares gained 45.7% over the last one month above the S&P 500’s increase of 21.3%. The company possesses a Momentum Score of B.
Ardmore Shipping Corporation Price
Ardmore Shipping Corporation price | Ardmore Shipping Corporation Quote
CorMedix, Inc. (CRMD - Free Report) : This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.9% over the last 60 days.
CorMedix Inc Price and Consensus
CorMedix Inc price-consensus-chart | CorMedix Inc Quote
CorMedix’s shares gained 48.5% over the last one month. The company possesses a Momentum Score of B.
CorMedix Inc Price
CorMedix Inc price | CorMedix Inc Quote
Arcimoto, Inc. : This manufacturer of three-wheeled electric vehicles has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 26.1% over the last 60 days.
Arcimoto, Inc. Price and Consensus
Arcimoto, Inc. price-consensus-chart | Arcimoto, Inc. Quote
Arcimoto’s shares gained 27.6% over the last one month. The company possesses a Momentum Score of B.
Arcimoto, Inc. Price
Arcimoto, Inc. price | Arcimoto, Inc. Quote
Ovid Therapeutics Inc. (OVID - Free Report) : This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25.4% over the last 60 days.
OVID THERAPEUTC Price and Consensus
OVID THERAPEUTC price-consensus-chart | OVID THERAPEUTC Quote
Ovid Therapeutics’ shares gained 38.9% over the last one month. The company possesses a Momentum Score of B.
OVID THERAPEUTC Price
OVID THERAPEUTC price | OVID THERAPEUTC Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>